Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.
Saved in:
| Title: | Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease. |
|---|---|
| Authors: | Kreijne, J. E.1,2 (AUTHOR) j.kreijne@erasmusmc.nl, Goetgebuer, R. L.1 (AUTHOR), Erler, N. S.3,4 (AUTHOR), De Boer, N. K.2 (AUTHOR), Siebers, A. G.5 (AUTHOR), Dijkstra, G.6 (AUTHOR), van Kemenade, F. A.7 (AUTHOR), Hoentjen, F.8,9 (AUTHOR), Oldenburg, B.10 (AUTHOR), van der Meulen, A. E.11 (AUTHOR), Ponsioen, C. I. J.12 (AUTHOR), Pierik, M. J.13 (AUTHOR), van der Woude, C. J.1 (AUTHOR), de Vries, A. C.1 (AUTHOR) a.c.devries@erasmusmc.nl |
| Source: | Alimentary Pharmacology & Therapeutics. Jul2023, Vol. 58 Issue 2, p207-217. 11p. 1 Diagram, 4 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.17555 |